Abstract
A 23-year-old White Australian male presented with hemoptysis 9 days after kidney transplantation. This was his second kidney transplant for Alport syndrome, with genetic confirmation of COL4A5 gene mutation. His first transplant, from his father, lasted 2 years and then failed due to a vascular rejection in the setting of nonadherence. His second transplant was human leukocyte antigen–DR matched and from a deceased donor with donation after brain death. The patient received standard induction with tacrolimus, mycophenolate mofetil, prednisolone, and basiliximab.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
